carvedilol has been researched along with Diabetic Angiopathies in 8 studies
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the metabolic and cardiovascular effects of carvedilol with those of atenolol in diabetic patients with hypertension." | 9.08 | Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. ( Acampora, R; D'Onofrio, F; De Angelis, L; De Rosa, N; Giugliano, D; Marfella, R; Ragone, R; Ziccardi, P, 1997) |
| "To compare the effects of the ACE inhibitor perindopril and the beta-blocker carvedilol on blood pressure and endothelial functions in NIDDM patients with hypertension." | 9.08 | Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension. ( Acampora, R; Coppola, L; D'Onofrio, F; Giugliano, D; Giunta, R; Marfella, R, 1998) |
| "Carvedilol is a beta-adrenergic antagonist with vasodilatory properties (alpha1-antagonism), which has been extensively evaluated in the treatment of patients with heart failure." | 8.84 | Carvedilol: use in chronic heart failure. ( Doughty, RN; White, HD, 2007) |
| " As comparisons to metoprolol succinate as well as to optimally dosed metoprolol tartrate are missing, a definite superiority of carvedilol cannot be assumed." | 5.34 | [Beta-adrenoceptor antagonists and ACE-inhibitors. Carvedilol compared with metoprolol as combination partner in cases of diabetes and hypertension]. ( Frese, T; Sandholzer, H, 2007) |
| "To compare the metabolic and cardiovascular effects of carvedilol with those of atenolol in diabetic patients with hypertension." | 5.08 | Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. ( Acampora, R; D'Onofrio, F; De Angelis, L; De Rosa, N; Giugliano, D; Marfella, R; Ragone, R; Ziccardi, P, 1997) |
| "To compare the effects of the ACE inhibitor perindopril and the beta-blocker carvedilol on blood pressure and endothelial functions in NIDDM patients with hypertension." | 5.08 | Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension. ( Acampora, R; Coppola, L; D'Onofrio, F; Giugliano, D; Giunta, R; Marfella, R, 1998) |
| "Carvedilol is a beta-adrenergic antagonist with vasodilatory properties (alpha1-antagonism), which has been extensively evaluated in the treatment of patients with heart failure." | 4.84 | Carvedilol: use in chronic heart failure. ( Doughty, RN; White, HD, 2007) |
| "In this study, 1235 participants with type 2 diabetes and hypertension who were receiving renin-angiotensin system blockers were randomized either to carvedilol, receiving 6." | 2.74 | Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients. ( Bakris, GL; Bell, DS; McGill, JB, 2009) |
| "Treatment with carvedilol for 5 weeks prevented the inhibition of endothelium-dependent relaxation and the decrease of serum NO levels caused by diabetes." | 1.34 | Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats. ( Chen, F; Fu, GS; Huang, H; Ke, XY; Qian, LB; Wang, HP; Xia, Q, 2007) |
| " As comparisons to metoprolol succinate as well as to optimally dosed metoprolol tartrate are missing, a definite superiority of carvedilol cannot be assumed." | 1.34 | [Beta-adrenoceptor antagonists and ACE-inhibitors. Carvedilol compared with metoprolol as combination partner in cases of diabetes and hypertension]. ( Frese, T; Sandholzer, H, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, SV | 1 |
| Spertus, JA | 1 |
| Lipska, KJ | 1 |
| Lanfear, DE | 1 |
| Tang, F | 1 |
| Grodzinsky, A | 1 |
| McGuire, DK | 1 |
| Gore, MO | 1 |
| Goyal, A | 1 |
| Maddox, TM | 1 |
| Kosiborod, M | 1 |
| Bell, DS | 1 |
| Bakris, GL | 1 |
| McGill, JB | 1 |
| Drábiková, K | 1 |
| Jancinová, V | 1 |
| Nosál', R | 1 |
| Solík, P | 1 |
| Murín, J | 1 |
| Holománová, D | 1 |
| Doughty, RN | 1 |
| White, HD | 1 |
| Fu, GS | 1 |
| Huang, H | 1 |
| Chen, F | 1 |
| Wang, HP | 1 |
| Qian, LB | 1 |
| Ke, XY | 1 |
| Xia, Q | 1 |
| Frese, T | 1 |
| Sandholzer, H | 1 |
| Giugliano, D | 2 |
| Acampora, R | 2 |
| Marfella, R | 2 |
| De Rosa, N | 1 |
| Ziccardi, P | 1 |
| Ragone, R | 1 |
| De Angelis, L | 1 |
| D'Onofrio, F | 2 |
| Giunta, R | 1 |
| Coppola, L | 1 |
1 review available for carvedilol and Diabetic Angiopathies
| Article | Year |
|---|---|
Carvedilol: use in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Diabe | 2007 |
4 trials available for carvedilol and Diabetic Angiopathies
| Article | Year |
|---|---|
Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 2009 |
On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Antioxidants; Carbazoles; Carvedilol; Di | 2006 |
Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Blood | 1997 |
Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Argi | 1998 |
3 other studies available for carvedilol and Diabetic Angiopathies
| Article | Year |
|---|---|
Type of β-blocker use among patients with versus without diabetes after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Contraindications; Diabetic Angiopathies; | 2014 |
Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Blotting, West | 2007 |
[Beta-adrenoceptor antagonists and ACE-inhibitors. Carvedilol compared with metoprolol as combination partner in cases of diabetes and hypertension].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Diabe | 2007 |